NuVasive Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Jefferies Reiterates Buy on NuVasive (NUVA) Following 3Q Report
October 26, 2016 8:34 AM EDTJefferies reiterated a Buy rating and $72.00 price target on NuVasive (NASDAQ: NUVA) following the company's 3Q earnings report. For the year, the company is now guiding to $952mn in sales (down from $962mn). Components of this include the US capital stocking issue of... More
NuVasive (NUVA) Reports In-Line Q3 EPS, Trims FY Revenue Guidance
October 25, 2016 5:02 PM EDTNuVasive (NASDAQ: NUVA) reported Q3 EPS of $0.40, in-line with the analyst estimate of $0.40. Revenue for the quarter came in at $239.6 million versus the consensus estimate of $243.52 million.
GUIDANCE:
NuVasive sees 2016 EPS of $1.64, versus the consensus of $1.65. NuVasive sees 2016 revenue of $954 million,... More
